These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10180833)

  • 1. Move forward with prostate Ca education despite lack of consensus over screening.
    Healthc Demand Dis Manag; 1998 Jun; 4(6):93-4. PubMed ID: 10180833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine prostate screening may be unnecessary and harmful.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(1):5-7. PubMed ID: 12762303
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus.
    Konety BR; Sharp VJ; Raut H; Williams RD
    Urology; 2008 Mar; 71(3):511-4. PubMed ID: 18342199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists as health educators and risk communicators in the early detection of prostate cancer.
    Odedina FT; Warrick C; Vilme H; Young S
    Res Social Adm Pharm; 2008 Mar; 4(1):59-66. PubMed ID: 18342823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counseling patients about prostate cancer screening.
    Foxhall LE; Von Eschenbach AC
    Am Fam Physician; 2002 May; 65(9):1752, 1754, 1757. PubMed ID: 12018801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer: who and how often?
    Schwartz K; Deschere B; Xu J
    J Fam Pract; 2005 Jul; 54(7):586-96. PubMed ID: 16009085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.
    Merrill RM
    Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer in general practice. Results of a five year prospective clinical study in one practice.
    Brett T
    Aust Fam Physician; 2001 Jul; 30(7):717-23. PubMed ID: 11558210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
    McDavid K; Melnik TA; Derderian H
    Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer: screening and treatment options.
    Horger DC; Clarke HS
    J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer screening: an individual decision.
    Holcomb SS
    Nurse Pract; 2007 Aug; 32(8):6-8. PubMed ID: 17667758
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer screening: knowledge, experiences and attitudes of men aged 40-79 years.
    Arroll B; Pandit S; Buetow S
    N Z Med J; 2003 Jun; 116(1176):U477. PubMed ID: 12835805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
    Reynolds TM
    J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.